losartan has been researched along with Neurilemmoma in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Neurilemmoma: A neoplasm that arises from SCHWANN CELLS of the cranial, peripheral, and autonomic nerves. Clinically, these tumors may present as a cranial neuropathy, abdominal or soft tissue mass, intracranial lesion, or with spinal cord compression. Histologically, these tumors are encapsulated, highly vascular, and composed of a homogenous pattern of biphasic fusiform-shaped cells that may have a palisaded appearance. (From DeVita Jr et al., Cancer: Principles and Practice of Oncology, 5th ed, pp964-5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Wu, L | 1 |
Vasilijic, S | 1 |
Sun, Y | 1 |
Chen, J | 1 |
Landegger, LD | 1 |
Zhang, Y | 1 |
Zhou, W | 1 |
Ren, J | 1 |
Early, S | 1 |
Yin, Z | 1 |
Ho, WW | 1 |
Zhang, N | 1 |
Gao, X | 1 |
Lee, GY | 1 |
Datta, M | 1 |
Sagers, JE | 1 |
Brown, A | 1 |
Muzikansky, A | 1 |
Stemmer-Rachamimov, A | 1 |
Zhang, L | 1 |
Plotkin, SR | 1 |
Jain, RK | 1 |
Stankovic, KM | 1 |
Xu, L | 1 |
1 other study available for losartan and Neurilemmoma
Article | Year |
---|---|
Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models.
Topics: Animals; Hearing Loss; Humans; Losartan; Mice; Neurilemmoma; Neurofibromatosis 2; Prospective Studie | 2021 |